Lorlatinib

About

Therapy type: Targeted therapy

Therapy strategy: ALK inhibition

Mappings

NCI Thesaurus: Lorlatinib (coding:ncit:C113655)

RxNorm: lorlatinib (coding:rxcui:2103164, coding:omop:35201733)

SNOMED: Lorlatinib (coding:sctid:782976007, coding:omop:37204343)

View API

Therapeutic response

Precision oncology relationships for therapeutic response involving this therapy.

Organizations Biomarkers Cancer types Therapies
FDA (1) HC (2) v::ALK Non-Small Cell Lung Cancer Lorlatinib